“Higher numbers of cases of [Guillan-Barre Syndrome] are seen in the period of two to four weeks after vaccination. A peak of cases observed around 24 days following a first dose,” said Professor Michael Lunn (UCL Queen Square Institute of Neurology).
Read: Express
Close
